626 related articles for article (PubMed ID: 21115502)
1. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol induces nuclear factor-κB activity in human cardiac cells.
Palomer X; Capdevila-Busquets E; Alvarez-Guardia D; Barroso E; Pallàs M; Camins A; Davidson MM; Planavila A; Villarroya F; Vázquez-Carrera M
Int J Cardiol; 2013 Sep; 167(6):2507-16. PubMed ID: 22748497
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
5. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
6. Sirt1 mediates the effects of a short-term high-fat diet on the heart.
Villarroya J; Redondo-Angulo I; Iglesias R; Giralt M; Villarroya F; Planavila A
J Nutr Biochem; 2015 Nov; 26(11):1328-37. PubMed ID: 26359030
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome Proliferator Activated Receptor-α Association With Silent Information Regulator 1 Suppresses Cardiac Fatty Acid Metabolism in the Failing Heart.
Oka S; Zhai P; Yamamoto T; Ikeda Y; Byun J; Hsu CP; Sadoshima J
Circ Heart Fail; 2015 Nov; 8(6):1123-32. PubMed ID: 26443578
[TBL] [Abstract][Full Text] [Related]
8. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
[TBL] [Abstract][Full Text] [Related]
12. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
14. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides.
Gao H; Feng XJ; Li ZM; Li M; Gao S; He YH; Wang JJ; Zeng SY; Liu XP; Huang XY; Chen SR; Liu PQ
Arch Biochem Biophys; 2015 Jan; 565():76-88. PubMed ID: 25436917
[TBL] [Abstract][Full Text] [Related]
16. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
17. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway.
Mishra A; Chaudhary A; Sethi S
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1621-7. PubMed ID: 15231516
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
19. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Davidson MM; Chan TO; Feldman AM; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2010 Aug; 87(3):449-58. PubMed ID: 20211864
[TBL] [Abstract][Full Text] [Related]
20. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]